CLINICAL_TRIALS
trial_result
· 2009-08-06
Clinical Trial Update: Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever [Phase 3]
Summary
Phase 3 trial assessing the efficacy and safety of SLITone Birch for allergic rhinitis (hay fever) has completed, with results posted on 2009-08-06.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 3 | Status: COMPLETED | Results posted: 2009-08-06